analyst forecast

Cambium Networks Stock Jumps on Starlink News as Delisting Looms – Analysts See 385% Upside

Stock Slumps Amid Delisting Fears Cambium Networks’ stock has been in a tailspin, reflecting both company-specific struggles and broader market skepticism. At just $0.62 per share as of Oct. 29, CMBM has lost nearly 90% of its value over the past 12 months finimize.com. This collapse wiped out hundreds of millions in market capitalization – the company is now valued at only ~$17 million investing.com, a stark contrast to its peers. (For example, rival Aviat Networks trades near $24 with a ~$250M market cap investors.aviatnetworks.com, underscoring how far Cambium has fallen behind.) Cambium’s share price briefly dipped into penny-stock territory

29 October 2025

BigBear.ai (BBAI) Stock Skyrockets on Defense AI Boom – Price, Deals & Analyst Forecast (Oct 24, 2025)

Stock run-up: BBAI shares are up roughly 80–100% year-to-date (2025) and over 300% from a year ago ts2.tech. The stock recently spiked on defense-AI deal news (hitting ~$9.39 on Oct 14) but has since cooled, trading around $6.6–$7.2 by Oct 22 ts2.tech fintel.io. – Latest deals: On Oct. 13 BigBear.ai announced a partnership with Tsecond to deploy its ConductorOS AI software on rugged field hardware – an “edge AI” solution for tactical military use ir.bigbear.ai ts2.tech. In September it teamed with SMX for the U.S. Navy’s UNITAS 2025 exercise, and on Oct. 23 rolled out its VeriScan facial-recognition system for

24 October 2025

Artificial Intelligence · Defense Industry · Investment · Market Analysis · NASDAQ:BBAI · Stocks

Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher – the world’s largest life-science tools and services firm – has seen its stock catch fire as investors bet on its growth strategy. Recent weeks’ gains come after a key rally in the biotech sector. For instance, a market report noted TMO’s stock “climb[ed] an impressive 9.79%” on Oct 1 as “market optimism swelled around a series of recent strategic developments” markets.financialcontent.com. That surge followed news of Thermo Fisher’s latest acquisitions and capacity expansions, underscoring management’s focus on high-growth areas like biologics manufacturing and lab automation. These moves build on strong fundamentals. Thermo Fisher’s Q2 2025 results (reported

21 October 2025

Biotech Industry · Financial News · Investment Analysis · Market Trends · Stock Market

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Stock Price & Recent Performance Equifax’s stock has been range-bound in recent weeks, hovering in the low-$230s per share. It closed at $231.12 on Oct. 20 investing.com, and despite a solid year-to-date performance in 2025, shares remain about 15% lower than a year ago investing.com. Elevated interest rates and recession worries weighed on credit industry stocks earlier this year. However, sentiment has improved recently as the Federal Reserve’s policy outlook turned more dovish this fall and tech-focused stocks rebounded. Equifax stock is up roughly 2% for 2025 so far, outperforming some peers, and has climbed about 50% over the past

21 October 2025

Earnings Reports · Equifax · Financial News · Investment Analysis · NYSE:EFX · Stock Market

Rivian Stock Could Plunge 23%: Analyst Warns of Gloomy EV Demand Ahead

Analysts Sound the Alarm on Demand. Following the Q3 report and guidance cut, analysts from Mizuho and others have raised red flags. Mizuho’s Vijay Rakesh emphasized that overall EV demand may be stagnating – “EV growth in North America is expected to stay flat in 2026,” he noted tipranks.com. He cut his 2026 delivery forecast to ~60,000 units (down from 68K prior) – well below the ~72K Wall Street consensus tipranks.com – arguing Rivian’s growth targets now look “too aggressive.” Rakesh specifically warned that with the end of the Inflation Reduction Act credits, EVs will become more expensive and demand

20 October 2025

Electric Vehicles · Financial News · Investment Analysis · Market Trends · NASDAQ:RIVN · Stock Market